| Autor: |
Zhechen Fan, Haroon Iqbal, Jiang Ni, Naveed Ullah Khan, Shahla Irshad, Anam Razzaq, Mohammad Y. Alfaifi, Serag Eldin I. Elbehairi, Ali A. Shati, Jianping Zhou, Hao Cheng |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
International Journal of Pharmaceutics: X, Vol 7, Iss , Pp 100238- (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2590-1567 |
| DOI: |
10.1016/j.ijpx.2024.100238 |
| Popis: |
The clinical advancement of protein-based nanomedicine has revolutionized medical professionals' perspectives on cancer therapy. Protein-based nanoparticles have been exploited as attractive vehicles for cancer nanomedicine due to their unique properties derived from naturally biomacromolecules with superior biocompatibility and pharmaceutical features. Furthermore, the successful translation of Abraxane™ (paclitaxel-based albumin nanoparticles) into clinical application opened a new avenue for protein-based cancer nanomedicine. In this mini-review article, we demonstrate the rational design and recent progress of protein-based nanoparticles along with their applications in cancer diagnosis and therapy from recent literature. The current challenges and hurdles that hinder clinical application of protein-based nanoparticles are highlighted. Finally, future perspectives for translating protein-based nanoparticles into clinic are identified. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
